US pension fund San Francisco Employees’ Retirement System (SFERS) has approved a capital commitment of up to $48 million to two investment vehicles launched by China-based biomedical venture capital firm Lilly Asia Ventures (LAV).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
